LEHI, Utah, July 24, 2025 /PRNewswire/ — Amare Global, The Mental Wellness Company™, is pleased to announce a powerful new chapter; effective immediately, David Chung, Owner and Chairman of Amare Global, will assume the role of Chief Executive Officer. With an unmatched passion for Amare’s mission and a relentless drive to see every brand partner succeed, Chung is stepping into this role to lead Brand Partners into the most exciting and expansive era in Amare history.
“We are grateful for Asma Ishaq’s leadership and wish her continued success,” said Chung of Amare’s former CEO.
Amare Global’s mission is to lead the global mental wellness movement under Chung’s visionary leadership. Chung relays, “Amare is shifting into high gear. This is a moment of alignment, acceleration, and absolute belief in our purpose, our people, and our potential. Brand Partners, now is your time. This shift will create greater stability as we invest deeper, dream bigger, and execute bolder than ever before. This is more than a leadership transition—it’s a leadership elevation.”
A serial entrepreneur, Chung has an extensive track record of building brands, developing cutting-edge innovation, and leading high-performance teams. Chung will focus on expanding innovation, driving global growth, and deepening Amare’s impact as an industry leader.
About Amare Global
Amare Global® is recognized as a category leader in the mental wellness movement, offering innovative solutions informed by the powerful relationship of the gut microbiome and the gut-brain axis (GBX). Dedicated to quality and backed by award-winning US patented formulations, Amare Global is committed to delivering transformative solutions that foster love—Amare means “to love” in Latin.
View original content:https://www.prnewswire.co.uk/news-releases/a-new-chapter-of-bold-leadership-and-unstoppable-growth-302512495.html
MUMBAI, India, April 15, 2026 /PRNewswire/ -- India's business leaders are backing AI with boardroom conviction,…
Organizations that treat consent as an ongoing data relationship—not a one-time transaction—are better positioned to…
Five-Year Contract Strengthens Partnership to Scale AI-Driven Sustainability Solutions in Metals and Materials ManufacturingATLANTA and…
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23,…
April 15, 2026 01:00 ET | Source: BioVersys BASEL, Switzerland, April 15, 2026 (GLOBE NEWSWIRE)…
REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology…